Variant report
Variant | nsv520499 |
---|---|
Chromosome Location | chr3:161193325-161195729 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:161192914..161194705-chr3:161200640..161203069,2 | MCF-7 | breast: | |
2 | chr3:161161602..161163726-chr3:161192340..161193989,2 | MCF-7 | breast: | |
3 | chr16:13221858..13222514-chr3:161192650..161193500,2 | MCF-7 | breast: | |
4 | chr3:161186330..161188713-chr3:161191015..161194014,3 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs16832441 | chr3:161193325-161193326 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs151195488 | chr3:161193357-161193358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs77985237 | chr3:161193531-161193532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs371026709 | chr3:161193712-161193713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs544066703 | chr3:161193714-161193715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs139258853 | chr3:161193716-161193717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs576229264 | chr3:161193719-161193720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs529038527 | chr3:161193770-161193771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs112319283 | chr3:161193788-161193789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs564228478 | chr3:161193790-161193791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574521808 | chr3:161193800-161193801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs564737779 | chr3:161193806-161193807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs183949663 | chr3:161193853-161193854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs144047053 | chr3:161193857-161193858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs561263732 | chr3:161193900-161193901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs186563715 | chr3:161193948-161193949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs16832443 | chr3:161193993-161193994 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs569787252 | chr3:161194049-161194050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs9854937 | chr3:161194059-161194060 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs552501725 | chr3:161194080-161194081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs561516842 | chr3:161194115-161194116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs62281471 | chr3:161194128-161194129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs398106651 | chr3:161194129-161194130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs397964076 | chr3:161194145-161194146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs373469574 | chr3:161194146-161194147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565923483 | chr3:161194276-161194277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs9835278 | chr3:161194277-161194278 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs554951325 | chr3:161194285-161194286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs146443928 | chr3:161194394-161194395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs537616735 | chr3:161194409-161194410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs76898494 | chr3:161194410-161194411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs535492504 | chr3:161194438-161194439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs9835582 | chr3:161194487-161194488 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs140824479 | chr3:161194488-161194489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs571926108 | chr3:161194489-161194490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs189629876 | chr3:161194513-161194514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs76345731 | chr3:161194529-161194530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs376401231 | chr3:161194544-161194545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs111525977 | chr3:161194584-161194585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs182320989 | chr3:161194588-161194589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186982954 | chr3:161194590-161194591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs552385645 | chr3:161194599-161194600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 21909424 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:161192400-161194600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr3:161193400-161194000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr3:161193400-161194400 | Enhancers | Liver | Liver |
4 | chr3:161193600-161194400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr3:161193800-161194400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr3:161193800-161194400 | Enhancers | Brain Inferior Temporal Lobe | brain |
7 | chr3:161193800-161194400 | Enhancers | Brain Substantia Nigra | brain |
8 | chr3:161193800-161194400 | Enhancers | Hela-S3 | cervix |